These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 4079004

  • 21. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection.
    Akhter T, Baqai R, Aziz M.
    Pak J Pharm Sci; 2010 Jan; 23(1):108-13. PubMed ID: 20067876
    [Abstract] [Full Text] [Related]

  • 22. Scope of urinary pathogens isolated in the Public Health Bacteriology Laboratory, Harare: antibiotic susceptibility patterns of isolates and incidence of haemolytic bacteria.
    Obi CL, Tarupiwa A, Simango C.
    Cent Afr J Med; 1996 Aug; 42(8):244-9. PubMed ID: 8990570
    [Abstract] [Full Text] [Related]

  • 23. Pridominant isolates of urinary tract pathogens and their antimicrobial susceptiblity patterns in Gondar University Teaching Hospital, nothwest Ethiopia.
    Tessema B, Kassu A, Mulu A, Yismaw G.
    Ethiop Med J; 2007 Jan; 45(1):61-7. PubMed ID: 17642159
    [Abstract] [Full Text] [Related]

  • 24. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
    Sader HS, Farrell DJ, Flamm RK, Jones RN.
    J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
    [Abstract] [Full Text] [Related]

  • 25. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). II. Background of patients].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H.
    Jpn J Antibiot; 1995 Nov; 48(11):1788-801. PubMed ID: 8558758
    [Abstract] [Full Text] [Related]

  • 26. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). II. Background of patients].
    Kosakai N, Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1989 Oct; 42(10):2175-88. PubMed ID: 2691715
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). II. Background of patients].
    Kosakai N, Kumamoto Y, Sakai S, Hirose T, Shigeta S, Shiraiwa Y, Miura Y, Ogata M, Tazaki H, Iri H.
    Jpn J Antibiot; 1986 Nov; 39(11):3007-18. PubMed ID: 3546775
    [Abstract] [Full Text] [Related]

  • 29. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
    Assefa A, Asrat D, Woldeamanuel Y, G/Hiwot Y, Abdella A, Melesse T.
    Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
    [Abstract] [Full Text] [Related]

  • 30. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Watanabe K, Kobayashi Y, Matsukawa M, Uchida H, Kunishima Y, Hirose T, Matsuda S, Sato S, Shigeta S, Fujime M, Fujita K, Yamaguti O, Ogihara M, Ishibashi K, Igari J, Takahashi K, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Furuya N, Kashitani F, Murai M, Ooe H, Nishikawa M, Kumon H, Monden K, Oka T, Kitamura M, Kohno S, Tomono K, Miyazaki Y, Matsuoka Y, Fukuhara Y, Hirakata Y, Aoki S.
    Jpn J Antibiot; 2003 Oct; 56(5):396-423. PubMed ID: 14692378
    [Abstract] [Full Text] [Related]

  • 31. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). III. Secular changes in susceptibility].
    Kosaki N, Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1989 Oct; 42(10):2189-312. PubMed ID: 2607604
    [Abstract] [Full Text] [Related]

  • 32. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). III. Secular changes in susceptibility].
    Kosakai N, Kumamoto Y, Sakai S, Hirose T, Okayama S, Shigeta S, Shiraiwa Y, Yoshida H, Miura Y, Ogata M.
    Jpn J Antibiot; 1987 Dec; 40(12):2026-142. PubMed ID: 3448256
    [Abstract] [Full Text] [Related]

  • 33. Changing pattern of antimicrobial susceptibility of organisms causing community acquired urinary tract infections.
    Farooqi BJ, Shareeq F, Rizvi QK, Qureshi HS, Ashfaq MK.
    J Pak Med Assoc; 2000 Nov; 50(11):369-73. PubMed ID: 11126812
    [Abstract] [Full Text] [Related]

  • 34. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). III. Secular changes in susceptibility].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1995 Nov; 48(11):1671-756. PubMed ID: 8558756
    [Abstract] [Full Text] [Related]

  • 35. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?
    Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari AC, Gales AC.
    Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):741-8. PubMed ID: 17160281
    [Abstract] [Full Text] [Related]

  • 36. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A.
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [Abstract] [Full Text] [Related]

  • 37. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, Takahashi S, Matsumoto T, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Deguchi T, Matsumoto M, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Wakeda H, Amemoto Y, Onodera S, Goto H, Komeda H, Yamashita M, Takenaka T, Fujimoto Y, Tsugawa M, Takahashi Y, Maeda H, Onishi H, Ishitoya S, Nishimura K, Mitsumori K, Ito T, Togo Y, Nakamura I, Ito N, Kanamaru S, Hirose T, Muranaka T, Yamada D, Ishihara S, Oka H, Inatomi H, Matsui T, Kobuke M, Kunishima Y, Kimura T, Ichikawa T, Kagara I, Matsukawa M, Takahashi K, Mita K, Kato M, Okumura K, Kawanishi H, Hashimura T, Aoyama T, Shigeta M, Koda S, Taguchi K, Matsuda Y.
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [Abstract] [Full Text] [Related]

  • 38. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution].
    Kosakai N, Kumamoto Y, Sakai S, Hirose T, Shigeta S, Shiraiwa Y, Miura Y, Ogata M, Tazaki H, Iri H.
    Jpn J Antibiot; 1986 Nov; 39(11):2959-3006. PubMed ID: 3102808
    [Abstract] [Full Text] [Related]

  • 39. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö, Zarakolu P, Aşçioğlu S, Etgül S, Uz B, Büyükaşik Y, Akova M.
    Infect Dis (Lond); 2015 Nov; 47(10):686-93. PubMed ID: 26024284
    [Abstract] [Full Text] [Related]

  • 40. [Clinical significance of infection pathogen resistance in a urological clinic for selection of antibacterial therapy regimes for the treatment of complicated urinary infections].
    Lopatkin NA, Derevianko II, Nefedova LA, Lavrinova LN, Prudnikova SA.
    Antibiot Khimioter; 2001 Nov; 46(6):21-6. PubMed ID: 11573320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.